The trifunctional antibody catumaxomab: Correlation between immunological response and clinical outcome—New analysis of a pivotal phase II/III study

Autor:	M. G. Ott, Horst Lindhofer, R. Linke, M. Hennig, H. Martinius, D. Seimetz, A. Klein
Rok vydání:	2010
Předmět:	Oncology Cancer Research medicine.medical_specialty biology business.industry Catumaxomab Trifunctional antibody Intraperitoneal treatment Internal medicine Immunology Ascites medicine biology.protein Antibody medicine.symptom business medicine.drug
Zdroj:	Journal of Clinical Oncology. 28:2551-2551
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.2551
Popis:	2551 Background: Catumaxomab, a trifunctional anti-EpCAM/anti-CD3 antibody is approved in the EU for intraperitoneal treatment of malignant ascites. In the pivotal study (Parsons et al. J Clin Onco...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::afb4ebc730fa99e330635b3454920f2e https://doi.org/10.1200/jco.2010.28.15_suppl.2551 Zobrazit plný text záznamu